Merck stock jumps as Keytruda sales beat expectations : vima

The pharma giant's patent of Keytruda is set to expire later this decade

Related Keywords

Robertm Davis , , York Stock Exchange Merck , Merck Co , New York Stock Exchange , Andrew Kelly , New Jersey Based , Wall Street , Merck , Blockbuster , Keytruda , Antineoplastic Drugs , Health , Medical , Dharma , Actset , Pembrolizumab , Schering Plough , Pharmaceutical Industry , Kenilworth , New Jersey , Merck Amp Co , Player , Business , Inance , Orphan Drugs , Uartz ,